European Society of Cardiology. (2021). Guidelines for the management of cardiovascular diseases during cardiac surgery. European Heart Journal, 42(15), 1459-1524.
[2]
American Heart Association. (2022). Management of postoperative cardiac dysfunction in adult cardiac surgery patients. Circulation, 146(12), e234-e278.
[3]
Lamy, A., et al. (2016). Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. New England Journal of Medicine, 375(24), 2359-2368.
[4]
Møller, C. H., et al. (2019). Postoperative myocardial dysfunction: mechanisms and clinical implications. Journal of Cardiothoracic and Vascular Anesthesia, 33(8), 2289-2301.
[5]
Society of Thoracic Surgeons. (2020). Adult cardiac surgery database: risk adjustment model. Annals of Thoracic Surgery, 110(3), 845-858.
[6]
Ranucci, M., et al. (2018). Postoperative dysfunction and mortality after cardiac surgery: a prospective observational study. Journal of Thoracic and Cardiovascular Surgery, 156(4), 1516-1525.
[7]
Kappetein, A. P., et al. (2016). Current indications for transcatheter aortic valve implantation. European Heart Journal, 37(4), 334-339.
[8]
Nissinen, J., et al. (2019). Management of low cardiac output syndrome after cardiac surgery. Annals of Cardiac Anaesthesia, 22(3), 289-297.
[9]
Landoni, G., et al. (2017). Levosimendan for hemodynamic support after cardiac surgery. New England Journal of Medicine, 376(21), 2021-2031.
[10]
Hillis, L. D., et al. (2011). ACC/AHA guideline for coronary artery bypass graft surgery. Journal of the American College of Cardiology, 58(24), e123-e210.